Caris Life Sciences, Inc. (CAI)

Caris Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	797.8	65.44	60.01	111.14
Short-Term Investments	2.3	2.2	65.18	302.43
Cash & Short-Term Investments	800.09	67.64	125.19	413.57
Cash Growth	1082.82%	-45.97%	-69.73%	-
Accounts Receivable	112.14	88.24	55.3	40.23
Inventory	63.63	39.57	49	46.96
Other Current Assets	21.94	20.27	13.12	15.29
Total Current Assets	997.8	215.73	242.61	516.04
Net Property, Plant & Equipment	63.17	67.82	107.09	138.05
Goodwill	19.34	19.34	19.34	19.34
Other Long-Term Assets	45.35	40.84	43.86	43.99
Total Assets	1,126	343.73	412.9	717.42
Accounts Payable	39.21	27.79	26.68	27.27
Accrued Expenses	87.77	77.54	68.29	56.85
Current Portion of Long-Term Debt	0.17	60.09	0.17	52.79
Total Current Liabilities	127.15	165.42	95.14	136.91
Long-Term Debt	378.82	319.44	166.42	169.57
Other Long-Term Liabilities	42.39	136.06	171.01	158.88
Total Long-Term Liabilities	421.21	455.5	337.43	328.46
Total Liabilities	548.36	620.92	432.57	465.36
Common Stock	0.28	0.04	0.04	0.14
Treasury Stock	-16.9	-0.33	-0.33	-0.33
Additional Paid-in Capital	3,142	-26.46	-25.7	-24.97
Accumulated Other Comprehensive Income	-	0.21	0.22	1.7
Retained Earnings	-	-2,472	-2,119	-1,679
Total Common Shareholders' Equity	3,125	-2,499	-2,145	-1,702
Minority Interest	-	2,222	2,125	1,954
Shareholders' Equity	3,125	-277.19	-19.67	252.06
Total Liabilities & Equity	1,126	343.73	412.9	717.42
Total Debt	378.99	379.53	166.59	222.36
Net Cash (Debt)	421.1	-311.89	-41.4	191.21
Net Cash Per Share	2.52	-8.79	-1.19	5730.70
Book Value	3,125	-2,499	-2,145	-1,702
Book Value Per Share	18.69	-70.40	-61.38	-51013.78
Tangible Book Value	3,106	-2,518	-2,164	-1,721
Tangible Book Value Per Share	18.57	-70.94	-61.94	-51593.54

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q